NPI: 1891973939 · LEBANON, VA 24266 · General Acute Care Hospital · NPI assigned 01/31/2008
Authorized official HILTON, SHANE controls 20+ related entities in our dataset. Read more
| Authorized Official | HILTON, SHANE (EVP/CFO) |
| NPI Enumeration Date | 01/31/2008 |
Other providers sharing the same authorized official: HILTON, SHANE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 47,640 | $1.04M |
| 2019 | 57,977 | $1.55M |
| 2020 | 41,580 | $1.37M |
| 2021 | 44,428 | $1.73M |
| 2022 | 45,463 | $1.91M |
| 2023 | 46,970 | $2.15M |
| 2024 | 32,371 | $1.62M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 19,826 | 16,929 | $3.08M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 15,159 | 13,115 | $1.99M |
| 96361 | Intravenous infusion, hydration; each additional hour | 5,002 | 3,920 | $1.17M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8,692 | 7,392 | $1.07M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,396 | 2,188 | $496K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,605 | 2,280 | $438K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,839 | 2,589 | $385K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,966 | 1,751 | $383K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 6,120 | 5,580 | $308K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,515 | 1,931 | $205K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4,149 | 963 | $186K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,033 | 1,587 | $168K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,261 | 1,094 | $130K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,126 | 2,715 | $126K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 685 | 625 | $122K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 804 | 675 | $111K |
| 80053 | Comprehensive metabolic panel | 24,214 | 18,886 | $111K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,437 | 1,605 | $107K |
| G0378 | Hospital observation service, per hour | 953 | 752 | $83K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 188 | 183 | $61K |
| 71046 | Radiologic examination, chest; 2 views | 3,854 | 3,448 | $46K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,028 | 994 | $45K |
| 36415 | Collection of venous blood by venipuncture | 17,443 | 12,557 | $34K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 25,055 | 19,252 | $31K |
| 72100 | 1,264 | 1,172 | $26K | |
| 87040 | 3,987 | 2,040 | $23K | |
| 73562 | 1,574 | 1,312 | $22K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,590 | 1,445 | $20K |
| 84443 | Thyroid stimulating hormone (TSH) | 4,780 | 4,267 | $19K |
| 83880 | 2,627 | 2,125 | $18K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 72 | 51 | $16K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7,863 | 5,926 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,101 | 2,517 | $15K |
| 73130 | 1,142 | 993 | $14K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 144 | 131 | $13K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,248 | 1,061 | $13K |
| 73610 | 1,071 | 927 | $13K | |
| 80061 | Lipid panel | 2,472 | 2,278 | $13K |
| 73630 | 1,151 | 995 | $12K | |
| 73030 | 742 | 667 | $12K | |
| 80329 | 1,135 | 531 | $12K | |
| 71250 | 164 | 156 | $12K | |
| 71045 | Radiologic examination, chest; single view | 5,454 | 4,502 | $10K |
| 84484 | 7,011 | 4,806 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,457 | 5,147 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,130 | 1,989 | $10K |
| 73110 | 507 | 429 | $9K | |
| 82607 | 1,869 | 1,681 | $9K | |
| J3490 | Unclassified drugs | 1,610 | 1,226 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 8,560 | 7,100 | $7K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 50 | 30 | $6K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 28 | 27 | $6K |
| 72125 | Computed tomography, cervical spine; without contrast material | 113 | 105 | $6K |
| 97035 | 107 | 36 | $5K | |
| 85027 | 2,499 | 2,155 | $5K | |
| 82728 | 1,468 | 1,297 | $5K | |
| 95811 | 13 | 12 | $5K | |
| 74018 | 428 | 387 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 217 | 212 | $4K |
| 80320 | 775 | 631 | $4K | |
| 81001 | 7,358 | 6,356 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 660 | 593 | $3K |
| 90715 | 196 | 186 | $3K | |
| 83605 | 3,159 | 2,416 | $3K | |
| 83550 | 754 | 705 | $3K | |
| 84439 | 541 | 488 | $3K | |
| 12001 | 13 | 13 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,769 | 4,506 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 183 | 149 | $3K |
| 83690 | 5,441 | 4,576 | $3K | |
| 83540 | 1,394 | 1,254 | $2K | |
| 83735 | 3,127 | 2,357 | $2K | |
| 86140 | 990 | 851 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,482 | 3,623 | $2K |
| 81003 | 4,666 | 4,061 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 16 | 15 | $2K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 15 | 13 | $2K |
| 85379 | 432 | 387 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 16 | 13 | $2K |
| 85610 | 1,722 | 1,247 | $2K | |
| 73502 | 151 | 130 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 14 | 13 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,482 | 1,308 | $1K |
| 87088 | 1,053 | 876 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 216 | 187 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,604 | 3,253 | $1K |
| 87186 | 1,177 | 1,023 | $1K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 326 | 91 | $1K |
| 93971 | 16 | 13 | $1K | |
| 81025 | 2,435 | 2,200 | $1K | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 496 | 409 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 5,072 | 4,288 | $1K |
| 97014 | 82 | 25 | $1K | |
| 82570 | 359 | 328 | $1K | |
| 87077 | 1,923 | 1,750 | $1K | |
| 80143 | 503 | 453 | $990.95 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,514 | 1,597 | $923.59 |
| 96523 | 15 | 12 | $851.39 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,074 | 896 | $805.82 |
| 82043 | 267 | 254 | $666.89 | |
| 85651 | 433 | 367 | $646.52 | |
| 96376 | 1,718 | 1,209 | $632.83 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,868 | 1,758 | $606.61 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 279 | 244 | $593.70 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,726 | 2,168 | $548.40 |
| 97162 | 41 | 38 | $533.43 | |
| 82746 | 236 | 211 | $504.95 | |
| 73080 | 42 | 38 | $498.67 | |
| 80179 | 492 | 444 | $483.40 | |
| 85652 | 563 | 463 | $478.40 | |
| 87522 | Neg quan hep c or qual rna | 24 | 14 | $430.34 |
| 84466 | 498 | 418 | $415.08 | |
| 82140 | 284 | 225 | $385.72 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 42 | 40 | $375.96 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,360 | 990 | $324.65 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,656 | 1,440 | $293.19 |
| J7030 | Infusion, normal saline solution , 1000 cc | 760 | 588 | $261.12 |
| 84703 | 1,092 | 990 | $236.28 | |
| 83615 | 359 | 269 | $235.29 | |
| 84100 | 286 | 227 | $199.31 | |
| 80076 | 15 | 13 | $182.93 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 13 | 12 | $93.34 |
| J2060 | Injection, lorazepam, 2 mg | 79 | 62 | $91.64 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 904 | 694 | $73.27 |
| 87081 | 751 | 695 | $72.64 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,122 | 967 | $64.52 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,462 | 1,388 | $61.87 |
| 74022 | 13 | 13 | $57.50 | |
| 85007 | 81 | 76 | $47.22 | |
| 80074 | 13 | 12 | $45.95 | |
| 82803 | 119 | 92 | $30.30 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 13 | 12 | $29.83 |
| 82550 | 136 | 119 | $28.68 | |
| 85730 | 54 | 49 | $25.66 | |
| 82533 | 19 | 13 | $22.66 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 390 | 333 | $21.13 |
| J8540 | Dexamethasone, oral, 0.25 mg | 101 | 77 | $19.58 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 249 | 176 | $16.85 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 323 | 222 | $15.72 |
| 85045 | 15 | 15 | $15.51 | |
| 87807 | 130 | 124 | $13.58 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 192 | 167 | $12.67 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 95 | 81 | $9.42 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 79 | 64 | $4.20 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 31 | 29 | $3.24 |
| J7050 | Infusion, normal saline solution, 250 cc | 50 | 30 | $2.95 |
| J1170 | Injection, hydromorphone, up to 4 mg | 25 | 12 | $2.67 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 49 | 38 | $1.85 |
| C9113 | Injection, pantoprazole sodium, per vial | 19 | 14 | $1.13 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 17 | 12 | $1.12 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 77 | 67 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 76 | 62 | $0.00 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 15 | 15 | $0.00 |
| 94760 | 306 | 140 | $0.00 | |
| A9270 | Non-covered item or service | 41 | 28 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 78 | 69 | $0.00 |
| 82150 | 17 | 14 | $0.00 | |
| L4350 | Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf | 15 | 14 | $0.00 |